vs
Side-by-side financial comparison of CVR ENERGY INC (CVI) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
CVR ENERGY INC is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -8.1%, a 12.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 20.3%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $21.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 0.3%).
CVR Energy Inc is a United States-based energy holding company operating two core segments: petroleum refining and nitrogen fertilizer manufacturing. It produces a wide range of products including gasoline, diesel, jet fuel, and agricultural fertilizers, primarily serving commercial, industrial and agricultural customers across North America.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CVI vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.5B |
| Net Profit | $-160.0M | $66.5M |
| Gross Margin | -5.2% | 90.5% |
| Operating Margin | — | 12.4% |
| Net Margin | -8.1% | 4.4% |
| Revenue YoY | 20.3% | 32.8% |
| Net Profit YoY | -56.1% | 143.8% |
| EPS (diluted) | $-1.91 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.9B | $1.4B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.9B | $1.1B | ||
| Q3 24 | $1.8B | $1.0B | ||
| Q2 24 | $2.0B | $929.2M |
| Q1 26 | $-160.0M | — | ||
| Q4 25 | $-110.0M | $66.5M | ||
| Q3 25 | $374.0M | $124.8M | ||
| Q2 25 | $-114.0M | $94.3M | ||
| Q1 25 | $-123.0M | $1.3M | ||
| Q4 24 | $28.0M | $-151.9M | ||
| Q3 24 | $-124.0M | $-121.3M | ||
| Q2 24 | $21.0M | $-120.4M |
| Q1 26 | -5.2% | — | ||
| Q4 25 | -3.1% | 90.5% | ||
| Q3 25 | 28.8% | 86.1% | ||
| Q2 25 | -3.7% | 87.5% | ||
| Q1 25 | -5.5% | 85.2% | ||
| Q4 24 | 3.0% | 85.8% | ||
| Q3 24 | -3.9% | 83.0% | ||
| Q2 24 | 2.9% | 85.1% |
| Q1 26 | — | — | ||
| Q4 25 | -5.3% | 12.4% | ||
| Q3 25 | 26.3% | 11.5% | ||
| Q2 25 | -5.8% | 6.7% | ||
| Q1 25 | -8.0% | 1.0% | ||
| Q4 24 | 1.1% | -7.0% | ||
| Q3 24 | -6.2% | -12.0% | ||
| Q2 24 | 1.4% | -11.5% |
| Q1 26 | -8.1% | — | ||
| Q4 25 | -6.1% | 4.4% | ||
| Q3 25 | 19.2% | 8.8% | ||
| Q2 25 | -6.5% | 7.2% | ||
| Q1 25 | -7.5% | 0.1% | ||
| Q4 24 | 1.4% | -13.5% | ||
| Q3 24 | -6.8% | -12.1% | ||
| Q2 24 | 1.1% | -13.0% |
| Q1 26 | $-1.91 | — | ||
| Q4 25 | $-1.09 | $0.05 | ||
| Q3 25 | $3.72 | $0.08 | ||
| Q2 25 | $-1.14 | $0.06 | ||
| Q1 25 | $-1.22 | $0.00 | ||
| Q4 24 | $0.28 | $-0.10 | ||
| Q3 24 | $-1.24 | $-0.09 | ||
| Q2 24 | $0.21 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $512.0M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | — | $4.4B |
| Total Assets | $3.9B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $512.0M | — | ||
| Q4 25 | $511.0M | $4.5B | ||
| Q3 25 | $670.0M | $4.0B | ||
| Q2 25 | $596.0M | $2.8B | ||
| Q1 25 | $695.0M | $2.5B | ||
| Q4 24 | $987.0M | $2.6B | ||
| Q3 24 | $534.0M | $2.7B | ||
| Q2 24 | $586.0M | $2.6B |
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $836.4M | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — |
| Q1 26 | — | — | ||
| Q4 25 | $730.0M | $4.4B | ||
| Q3 25 | $840.0M | $4.1B | ||
| Q2 25 | $466.0M | $3.8B | ||
| Q1 25 | $580.0M | $3.5B | ||
| Q4 24 | $703.0M | $3.3B | ||
| Q3 24 | $675.0M | $3.4B | ||
| Q2 24 | $849.0M | $3.4B |
| Q1 26 | $3.9B | — | ||
| Q4 25 | $3.7B | $8.2B | ||
| Q3 25 | $4.0B | $7.6B | ||
| Q2 25 | $4.0B | $6.3B | ||
| Q1 25 | $4.3B | $5.8B | ||
| Q4 24 | $4.3B | $5.9B | ||
| Q3 24 | $3.9B | $5.8B | ||
| Q2 24 | $4.0B | $5.7B |
| Q1 26 | — | — | ||
| Q4 25 | 2.40× | 0.19× | ||
| Q3 25 | 2.17× | — | ||
| Q2 25 | 3.97× | — | ||
| Q1 25 | 3.29× | — | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 1.86× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | $21.0M | $379.8M |
| FCF MarginFCF / Revenue | 1.1% | 25.4% |
| Capex IntensityCapex / Revenue | 1.5% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $0 | $417.3M | ||
| Q3 25 | $163.0M | $402.6M | ||
| Q2 25 | $176.0M | $263.6M | ||
| Q1 25 | $-195.0M | $44.1M | ||
| Q4 24 | $98.0M | $75.2M | ||
| Q3 24 | $48.0M | $188.4M | ||
| Q2 24 | $81.0M | $-95.6M |
| Q1 26 | $21.0M | — | ||
| Q4 25 | — | $379.8M | ||
| Q3 25 | $125.0M | $354.5M | ||
| Q2 25 | $135.0M | $219.8M | ||
| Q1 25 | $-246.0M | $-12.3M | ||
| Q4 24 | $43.0M | $-17.3M | ||
| Q3 24 | $14.0M | $54.7M | ||
| Q2 24 | $38.0M | $-205.5M |
| Q1 26 | 1.1% | — | ||
| Q4 25 | — | 25.4% | ||
| Q3 25 | 6.4% | 25.1% | ||
| Q2 25 | 7.7% | 16.7% | ||
| Q1 25 | -14.9% | -1.1% | ||
| Q4 24 | 2.2% | -1.5% | ||
| Q3 24 | 0.8% | 5.5% | ||
| Q2 24 | 1.9% | -22.1% |
| Q1 26 | 1.5% | — | ||
| Q4 25 | 3.0% | 2.5% | ||
| Q3 25 | 2.0% | 3.4% | ||
| Q2 25 | 2.3% | 3.3% | ||
| Q1 25 | 3.1% | 5.0% | ||
| Q4 24 | 2.8% | 8.2% | ||
| Q3 24 | 1.9% | 13.3% | ||
| Q2 24 | 2.2% | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.28× | ||
| Q3 25 | 0.44× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | 3.50× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
